| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Ralph C Budd | |
| P2860 | cites work | Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 |
| DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis | Q24313625 | ||
| Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
| Lamin proteolysis facilitates nuclear events during apoptosis | Q24681695 | ||
| Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity | Q28138855 | ||
| Mammalian caspases: structure, activation, substrates, and functions during apoptosis | Q28139429 | ||
| The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways | Q28145665 | ||
| Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis | Q28250587 | ||
| The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme | Q28256420 | ||
| A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD | Q28258328 | ||
| Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 | Q28265912 | ||
| Human ICE/CED-3 protease nomenclature | Q28293240 | ||
| Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis | Q28588677 | ||
| Caspases: enemies within | Q29547315 | ||
| A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis | Q29617776 | ||
| The Fas death factor | Q29620461 | ||
| Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity | Q33497763 | ||
| The modular nature of apoptotic signaling proteins | Q33708044 | ||
| Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis | Q34451533 | ||
| Stepwise reassembly of the nuclear envelope at the end of mitosis | Q36232741 | ||
| Migration and maturation of Langerhans cells in skin transplants and explants | Q36353813 | ||
| Caspase activation is required for T cell proliferation | Q36375598 | ||
| Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells | Q36375602 | ||
| Lethal effect of the anti-Fas antibody in mice | Q36696599 | ||
| Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload | Q39737479 | ||
| Parallels in T lymphocyte development between lpr and normal mice | Q40745055 | ||
| Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. | Q40918377 | ||
| Caspases and caspase inhibitors | Q41633125 | ||
| Fas transduces activation signals in normal human T lymphocytes | Q41906015 | ||
| Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory res | Q42020354 | ||
| Development of inflammatory angiogenesis by local stimulation of Fas in vivo. | Q42951575 | ||
| Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
| Immunological adjuvants promote activated T cell survival via induction of Bcl-3. | Q48367905 | ||
| The nuclear envelope lamina is reversibly depolymerized during mitosis | Q49487584 | ||
| Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. | Q51083614 | ||
| Premature p34cdc2 activation required for apoptosis. | Q52514157 | ||
| APO‐1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl‐2 oncogene expression | Q53023165 | ||
| Delayed kinetics of T lymphocyte anergy and deletion in lpr mice. | Q54190917 | ||
| Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. | Q64975773 | ||
| Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice | Q67901513 | ||
| Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha | Q68090327 | ||
| Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1 | Q70363596 | ||
| Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness | Q71615058 | ||
| Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor | Q71693197 | ||
| Changes in cell cycle-associated gene expression in a model of impaired liver regeneration | Q72067140 | ||
| Unraveling function in the TNF ligand and receptor families | Q72393346 | ||
| Fas ligand costimulates the in vivo proliferation of CD8+ T cells | Q73163098 | ||
| Fas engagement accelerates liver regeneration after partial hepatectomy | Q74133687 | ||
| Proteases to die for | Q74630246 | ||
| Mechanisms of hepatic toxicity. I. TNF-induced liver injury | Q77181185 | ||
| Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes | Q77353682 | ||
| Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor | Q77355546 | ||
| CD95(APO-1/Fas)-mediated apoptosis: live and let die | Q77903149 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 437-441 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Death receptors couple to both cell proliferation and apoptosis | |
| P478 | volume | 109 |
| Q51943967 | A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. |
| Q40257566 | A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis |
| Q34277875 | A historical perspective on sepsis |
| Q41609169 | A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation |
| Q34921969 | A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease |
| Q53572097 | ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. |
| Q36611899 | Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma |
| Q35091396 | All in the family: evolutionary and functional relationships among death receptors |
| Q36403284 | An essential role for c-FLIP in the efficient development of mature T lymphocytes |
| Q39737630 | Apoptosis and NF-kappa B: the FADD connection |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q44569551 | Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation |
| Q35110757 | Biomolecular cytokine therapy |
| Q35084316 | Breast cancer as a model of realistic challenges in pharmacogenomics |
| Q41963150 | CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling |
| Q37388115 | Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome. |
| Q47582812 | Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines |
| Q48884086 | Death receptor 5 and neuroproliferation |
| Q37660616 | Death receptors: targets for cancer therapy |
| Q35857019 | Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization |
| Q35604229 | Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation |
| Q45085314 | Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. |
| Q46947457 | Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. |
| Q44225515 | Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production |
| Q51811369 | Enhanced T-cell apoptosis in human septic shock is associated with alteration of the costimulatory pathway. |
| Q35964742 | Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity |
| Q51425342 | Expression of Fas, FasL, caspase-8 and other factors of the extrinsic apoptotic pathway during the onset of interdigital tissue elimination. |
| Q39345317 | Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors |
| Q40468705 | Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells. |
| Q33676532 | Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand. |
| Q53603763 | Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1. |
| Q54473724 | Involvement of the apelin receptor APJ in Fas-induced liver injury. |
| Q39009229 | Licochalcone A as a potent antitumor agent suppresses growth of human oral cancer SCC-25 cells in vitro via caspase-3 dependent pathways |
| Q51870712 | Mathematical modeling identified c-FLIP as an apoptotic switch in death receptor induced apoptosis. |
| Q57384575 | Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity |
| Q73839432 | Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody |
| Q96155770 | Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs) |
| Q28629323 | N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway |
| Q44569270 | Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation |
| Q42573914 | Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. |
| Q40623081 | Phosphatidylinositide 3-Kinase Priming Couples c-FLIP to T Cell Activation |
| Q35222080 | Physiological functions of caspases beyond cell death |
| Q38306010 | Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity |
| Q33554139 | Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells |
| Q28601538 | Programmed cell death 50 (and beyond) |
| Q44597152 | Quiescent CD34+ early erythroid progenitors are resistant to several erythropoietic 'inhibitory' cytokines; role of FLIP. |
| Q44608411 | Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege |
| Q39641284 | Rosmarinic Acid Antagonized 1-Methyl-4-Phenylpyridinium (MPP+)-Induced Neurotoxicity in MES23.5 Dopaminergic Cells |
| Q23921468 | S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-kappa B |
| Q34912414 | Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence |
| Q35140893 | Significance of endothelial cell survival programs for renal transplantation |
| Q36001216 | Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms |
| Q40649955 | TGF‐β1 modulates Fas (APO‐1/CD95)‐mediated apoptosis of human pre‐B cell lines |
| Q53923667 | TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. |
| Q44482351 | TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. |
| Q42937750 | Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion |
| Q40628674 | The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway |
| Q40380312 | The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. |
| Q36167596 | The anaemia of cancer: death by a thousand cuts |
| Q24299508 | The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER |
| Q34017062 | The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling |
| Q35836872 | The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention |
| Q73934118 | c-FLICE inhibitory protein expression inhibits T-cell activation |
| Q34015848 | p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis. |
Search more.